Charles River Laboratories International (CRL) Share-based Compensation (2009 - 2026)

Charles River Laboratories International has reported Share-based Compensation for 18 years, with the latest figure at $19.8 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 16.02% year-over-year to $19.8 million in Q2 2026; TTM through Jun 2026 was $83.1 million, a 24.44% increase from a year earlier, with the FY2025 full-year figure at $71.1 million, up 1.71% from the prior year.
• Share-based Compensation was $19.8 million for Q2 2026 at Charles River Laboratories International, down from $22.4 million in the prior quarter.
• The five-year high for Share-based Compensation was $23.3 million in Q3 2025, with the low at $13.1 million in Q1 2025.
• Average Share-based Compensation over 5 years is $18.3 million, with a median of $17.4 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation retreated 21.53% in 2025, then jumped 70.39% in 2026.
• Over 5 years, Share-based Compensation stood at $22.1 million in 2022, then dropped by 11.55% to $19.5 million in 2023, then dropped by 11.71% to $17.2 million in 2024, then grew by 2.3% to $17.6 million in 2025, then grew by 12.19% to $19.8 million in 2026.
• The last three Share-based Compensation figures came in at $19.8 million (Q2 2026), $22.4 million (Q1 2026), and $17.6 million (Q4 2025), per Business Quant data.